|Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection.|
NJD Lundgren JD, Babiker AG, Gordin F, Emery S, Grund B, Sharma S ...
N Engl J Med. 373 (9), 795-807, 2015
|Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries.|
P Braitstein, MW Brinkhof, F Dabis, M Schechter, A Boulle, P Miotti, ...
Lancet (London, England) 367 (9513), 817-824, 2006
|Comparison of first-line antiretroviral therapy with regimens including nevirapine, efavirenz, or both drugs, plus stavudine and lamivudine: a randomised open-label trial, the …|
F Van Leth, P Phanuphak, K Ruxrungtham, E Baraldi, S Miller, B Gazzard, ...
The Lancet 363 (9417), 1253-1263, 2004
|Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa|
SD Lawn, AD Harries, X Anglaret, L Myer, R Wood
AIDS (London, England) 22 (15), 2008
|Effect of highly active antiretroviral therapy on incidence of tuberculosis in South Africa: a cohort study|
M Badri, D Wilson, R Wood
The Lancet 359 (9323), 2059-2064, 2002
|Major clinical outcomes in antiretroviral therapy (ART)–naive participants and in those not receiving ART at baseline in the SMART study|
Strategies for Management of Antiretroviral Therapy (SMART) Study Group
The Journal of infectious diseases 197 (8), 1133-1144, 2008
|Tuberculosis among HIV-infected patients receiving HAART: long term incidence and risk factors in a South African cohort|
SD Lawn, M Badri, R Wood
Aids 19 (18), 2109-2116, 2005
|Early mortality among adults accessing a community-based antiretroviral service in South Africa: implications for programme design|
SD Lawn, L Myer, C Orrell, LG Bekker, R Wood
Aids 19 (18), 2141-2148, 2005
|Development of a standardized screening rule for tuberculosis in people living with HIV in resource-constrained settings: individual participant data meta-analysis of …|
H Getahun, W Kittikraisak, CM Heilig, EL Corbett, H Ayles, KP Cain, ...
PLoS Med 8 (1), e1000391, 2011
|Burden of tuberculosis in an antiretroviral treatment programme in sub-Saharan Africa: impact on treatment outcomes and implications for tuberculosis control|
SD Lawn, L Myer, LG Bekker, R Wood
Aids 20 (12), 1605-1612, 2006
|Adherence is not a barrier to successful antiretroviral therapy in South Africa|
C Orrell, DR Bangsberg, M Badri, R Wood
Aids 17 (9), 1369-1375, 2003
|Life expectancies of South African adults starting antiretroviral treatment: collaborative analysis of cohort studies|
LF Johnson, J Mossong, RE Dorrington, M Schomaker, CJ Hoffmann, ...
PLoS Med 10 (4), e1001418, 2013
|Tuberculosis-associated immune reconstitution disease: incidence, risk factors and impact in an antiretroviral treatment service in South Africa|
SD Lawn, L Myer, LG Bekker, R Wood
Aids 21 (3), 335-341, 2007
|Short-term and long-term risk of tuberculosis associated with CD4 cell recovery during antiretroviral therapy in South Africa|
SD Lawn, L Myer, D Edwards, LG Bekker, R Wood
AIDS (London, England) 23 (13), 1717, 2009
|Screening for HIV-associated tuberculosis and rifampicin resistance before antiretroviral therapy using the Xpert MTB/RIF assay: a prospective study|
SD Lawn, SV Brooks, K Kranzer, MP Nicol, A Whitelaw, M Vogt, ...
PLoS Med 8 (7), e1001067, 2011
|Screening for cryptococcal antigenemia in patients accessing an antiretroviral treatment program in South Africa|
JN Jarvis, SD Lawn, M Vogt, N Bangani, R Wood, TS Harrison
Clinical Infectious Diseases 48 (7), 856-862, 2009
|Undiagnosed tuberculosis in a community with high HIV prevalence: implications for tuberculosis control|
R Wood, K Middelkoop, L Myer, AD Grant, A Whitelaw, SD Lawn, ...
American journal of respiratory and critical care medicine 175 (1), 87-93, 2007
|Diagnostic accuracy of a low-cost, urine antigen, point-of-care screening assay for HIV-associated pulmonary tuberculosis before antiretroviral therapy: a descriptive study|
SD Lawn, AD Kerkhoff, M Vogt, R Wood
The Lancet infectious diseases 12 (3), 201-209, 2012
|Fungal burden, early fungicidal activity, and outcome in cryptococcal meningitis in antiretroviral-naive or antiretroviral-experienced patients treated with amphotericin B or …|
T Bicanic, G Meintjes, R Wood, M Hayes, K Rebe, LG Bekker, T Harrison
Clinical infectious diseases 45 (1), 76-80, 2007
|Nevirapine and efavirenz elicit different changes in lipid profiles in antiretroviral-therapy-naive patients infected with HIV-1|
F Van Leth, P Phanuphak, E Stroes, B Gazzard, P Cahn, F Raffi, R Wood, ...
PLoS Med 1 (1), e19, 2004